“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

Objectives

CoMMiTMenT aims to develop and validate the technologies of optofluidic microscopy and scanning ion conductance microscopy as novel methods to be combined in a µCOSMOS device. The individual imaging technologies, and to a larger extent the unique fusion of technologies will allow for the identification and probing of the molecular players that underlie rare anaemia. In doing so, this innovative technology will provide a novel diagnostic tool, a better understanding of the underlying pathophysiology of rare anaemia, and the possibility for the development of (personalised) treatments for this group of established, emerging, and as yet undiscovered RBC disorders.

Overview of the fields of RA-related research within CoMMiTMenT. The dark red ‘buttons’ represent the state of the art, and the light grey ‘buttons’ define the objectives. CoMMiTMenT aims to turn the light grey ‘buttons’ to dark red.